http://orcid.org/0000-0002-7174-4651
References
- Shah I, Gurnani S. Pericardial effusion as a paradoxical reaction on treatment with second-line antituberculous agents. Infect Dis (Lond). 2017;49: 318–319.
- Pereira NM, Shah I. Hydrocephalus in tuberculous meningitis - how late can it present? Infect Dis (Lond). 2017;49: 229–230.
- Im JH, Baek JH, Kwon HY, et al. Paradoxical reaction of tuberculous vertebral osteomyelitis: a case series. Infect Dis (Lond). 2015;47: 271–274.
- World Health Organization. Treatment of tuberculosis guidelines. 2010. Geneva: WHO press.
- Salvarani C, Brown RD, Christianson TJ, et al. Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients. Arthritis Rheumatol. 2015;67: 1637–1645.
- Gonzalez-Duarte A, Higuera-Calleja J, Flores F, et al. Cyclophosphamide treatment for unrelenting CNS vasculitis secondary to tuberculous meningitis. Neurology. 2012;78: 1277–1278.
- Blackmore TK, Manning L, Taylor WJ, et al. Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis. 2008;47: e83–e85.
- Cooray S, Zhang H, Breen R, et al. Cerebral tuberculosis in a patient with systemic lupus erythematosus following cyclophosphamide treatment: a case report. Lupus. 2017; 961203317722849.
- Martinez-Longoria CA, Rubio-Perez NE, Rios-Solis JE, et al. Severe meningoencephalitis co-infection due to Cryptococcus neoformans and Mycobacterium tuberculosis in a child with systemic lupus erythematosus. Int J Infect Dis. 2015;33:106–108.
- Nair R, Prabhash K, Sengar M, et al. The effect of short-term intensive chemotherapy on reactivation of tuberculosis. Ann Oncol. 2007;18: 1243–1245.